Main menu

Secondary menu

RXi Pharmaceuticals Talks Partnerships	Healthcare, Technology Converge: Recent Biotech Deals	CytRx: All That Glitters Could be Gold
Illumina Takes the Lead in Human Genome Project	Are RNAi Leaders About to Be Snatched Up by Big Pharma?	RXi Pharmaceuticals: What's Cooking?
RXi Pharmaceuticals Continues to Gain Momentum	RXi Pharmaceuticals Continues to Gain Momentum	15 Biotech Stocks With the Lowest Put/Call Ratios
18 Stocks on the 52 Week Low List Ready to Pop?	RXi Pharmaceuticals Deal Promises Huge Upside	Apthera Acquisition Puts RXi Pharmaceuticals in New League
Why 2011 Could Be a Big Year for Pharmaceutical M&A	5 Stocks Under $10 With New Insider Buying	Filling an Unmet Need: A Look at Generex and RXI Pharma's Breast Cancer Vaccines
Hunting for the Next Dendreon	Top Buy and Sell Ideas Based on Healthcare Sector's Q2 Losers	6 Companies That Could Revolutionize Medicine -- And Portfolios
Gambling With Speculative Healthcare Stocks	Why CytRx Corporation Is Still A Big Biotech 'If' Play	Galena Looks Undervalued Considering Cancer Therapy Results